PT  - JOURNAL ARTICLE
AU  - J. Comin
AU  - D. Kallmes
TI  - Clopidogrel (Plavix)
AID  - 10.3174/ajnr.A2913
DP  - 2011 Dec 01
TA  - American Journal of Neuroradiology
PG  - 2002--2004
VI  - 32
IP  - 11
4099  - http://www.ajnr.org/content/32/11/2002.short
4100  - http://www.ajnr.org/content/32/11/2002.full
SO  - Am. J. Neuroradiol.2011 Dec 01; 32
AB  - SUMMARY: Clopidogrel is an inhibitor of platelet aggregation, indicated for the prevention of ischemic stroke and in-stent thrombosis. However, it has a number of drawbacks, including an increased risk of hemorrhage; a clinical effect that is slow in onset and irreversible; a genetically determined variability in its clinical potency; and interactions with other commonly administered drugs. Act-Metactive metabolite of clopidogrelADPadenosine diphosphateAHAAmerican Hospital AssociationGIgastrointestinalGPIIb/IIIaglycoprotein IIb/IIIaPPIproton pump inhibitorVWFvon Willebrand factor